Target intelligence / Profile preview

Long intergenic non-protein coding RNA 869 (LINC00869)

Target
LINC00869
Molecular classification
Long non-coding RNA (lncRNA), Other (non-protein coding)
01

Overview

Long intergenic non-protein coding RNA 869 (LINC00869) is a long non-coding RNA, not encoding a protein, located on chromosome 1 (genomic coordinates: 1:149,606,333-149,705,716 in the human genome). It has several aliases including FAM91A2 and KIAA0493. LINC00869 is increasingly expressed in tumors such as hepatocellular carcinoma (HCC) and has been implicated in tumor progression and metastasis, particularly by regulating cytoskeletal dynamics (CDC42–WASP pathway). Gene expression studies and functional enrichment analyses suggest it is associated with processes such as mitochondrial gene expression and cellular energy metabolism. While it has not been reported as a direct therapeutic target, LINC00869 expression is under investigation as a prognostic biomarker in cancer, especially HCC. There is currently no known drug that directly interacts with LINC00869.

Other names
FAM91A2Family with sequence similarity 91 member A2KIAA0493LINC00869
02

Mechanism of action

Not applicable for drugs, but biological studies suggest: Modulation of cell migration and metastasis through regulation of the CDC42–WASP pathway. Possible biomarker for prognosis and risk stratification in hepatocellular carcinoma.

03

Biological functions

Regulation of gene expressionPotential role in mitochondrial gene expression and respiratory chain complex assemblyMay influence cell protrusion formation via the CDC42–WASP pathwayPossible involvement in tumor progression and metastasis (especially hepatocellular carcinoma)Other (non-coding RNA regulatory function)
04

Disease associations

Cancer (especially hepatocellular carcinoma—HCC)Other (data predominantly on cancer context)
05

Biomarkers

LINC00869 expression is a proposed biomarker for prognosis and risk prediction in hepatocellular carcinomaMay help stratify patients for immunotherapy response in HCC

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 869 (LINC00869).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 869 (LINC00869).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call